CABR Stock Analysis: Buy, Sell, or Hold?
$1.28
0.10 (8.47%)
▲
5d:
+10.34%
30d:
+35.08%
90d:
+45.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 4, 2026 12:00 AM ET
Earnings: Jun 30, 2026
24d
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CABR is 8.5% above its trading range ($1.18). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CABR is 8.5% above its trading range ($1.18). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $1.28, which is considered extended relative to its 30-day fair value range of $0.93 to $1.18.
Technical Outlook: Technically, CABR is in a uptrend. The price is approaching resistance at $1.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: CABR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CABR is in a uptrend. The price is approaching resistance at $1.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: CABR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.93 -
$1.18
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.8%
All Signals
- BEARISH: Price extended above range (+8.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.5%)
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.18
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$1.30
Current Trend
Uptrend
Technical data as of
Jun 4, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: June 05, 2026 8:05 AM ET
Data refreshes hourly during market hours. Next update: 9:05 AM
Data refreshes hourly during market hours. Next update: 9:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |